Idéal Investisseur Galteron Galteron
Français English
CAC 40 : Market closed
8 216,78 pts
-1.62%


Last updated : 17/11/2026 - 17h37
🏠 Home   ➤    Stock news

Ipsen shares fall back below their 167.40 € resistance and lose 2%

The Paris-based laboratory declines in a sharply lower Paris market. The stock had nevertheless touched an intraday high before giving back its gains.


Ipsen shares fall back below their 167.40 € resistance and lose 2%

A breakout above resistance quickly erased during the session

The Ipsen share price falls 1.97% to 164.10 €, while the SBF 120 loses 1.58% and the CAC 40 1.62%.

The stock had nevertheless broken above its 167.40 € resistance intraday, reaching a high of 168.10 €, before falling back below it. This failed breakout limits the day's decline, but the price remains above its 20-day moving average (MM20, a gap of 3.53%) and its 50-day moving average (MM50, a gap of 7.66%).

The 10.1% gain over one month and the 5.2% gain over three months are therefore still largely preserved.

The third-quarter guidance upgrade remains the reference point

Ipsen once again raised its annual revenue and margin growth targets in its nine-month results release on October 22, 2026. The group also flagged, among its risks, the early entry of a generic version of lanreotide in the fourth quarter, which would weigh on Somatuline sales.

On the outlook, two regulatory submissions are under way: Dysport for chronic and episodic migraine, and Iqirvo for primary biliary cholangitis. For the session, the 167.40 € level remains the one to watch.

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning ✓ Euronext data ✓ AI-powered analysis


Sector Pharmacie et biotechnologies › Pharmacie, vaccins et santé animale


Context

Period
  • Period: T3 2026
Key reported figures
  • Revenue: 1 174 millions d'euros
  • Quarterly revenue: 1 174 millions d'euros
  • Revenue growth: 28,3 %

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
✓ Avant 9h00 ✓ 1000+ inscrits ✓ 100% gratuit
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours sur les valeurs Euronext, chaque matin avant 9h.
tendance · 6 séances
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours